Clincosm LogoSign in Get a demo

A Retrospective Review of Infections Usually Observed in Transplant Recipients

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT00298077
Collaborator
(none)
500
Enrollment
2
Locations
130
Actual Duration (Months)
250
Patients Per Site
1.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study will identify patients with infections commonly observed in transplant recipients, describe the epidemiology of their infection, study the risk factors associated with various infections and examine strategies of early diagnosis and prevention of infection

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, previous medical surgical conditions, microbiology and virology culture results, laboratory and radiographical data, antimicrobial usage of onset of infection, microbiological data and resistance patterns, choice of antibiotics once organism identified, suspected source of infection, bacteriological outcomes, laboratory results, demographic information, pathology and histology results, summaries of admissions, discharges, operations, death, medications, clinical outcome gender, height, weight, ethnicity, date of transplant, type of transplant, primary diagnosis, and past medical history. Also required are medical summaries of admissions, discharges, operations, and deaths

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    500 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    A Retrospective Review of Infections Usually Observed in Transplant Recipients
    Actual Study Start Date :
    Aug 1, 2006
    Actual Primary Completion Date :
    Jun 1, 2017
    Actual Study Completion Date :
    Jun 1, 2017

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:

      • Patients who receive medical care at UPMC

      • Patients who developed infections usually observed in transplant recipients

      Exclusion:
      • Patients who do not receive medical care in UPMC Oakland campus

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213
      2 UPMC Pittsburgh Pennsylvania United States 15213

      Sponsors and Collaborators

      • University of Pittsburgh

      Investigators

      • Principal Investigator: Eun Kwak, MD, University of Pittsburgh

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      EJ Kwak, Assistant Professor, University of Pittsburgh
      ClinicalTrials.gov Identifier:
      NCT00298077
      Other Study ID Numbers:
      • IRB# 0602053
      First Posted:
      Mar 1, 2006
      Last Update Posted:
      Jun 12, 2018
      Last Verified:
      Jun 1, 2018
      Keywords provided by EJ Kwak, Assistant Professor, University of Pittsburgh
      Infection
      transplant recipients
      Additional relevant MeSH terms:
      Infections
      Communicable Diseases

      Study Results

      No Results Posted as of Jun 12, 2018